.webp)
Glynux M 2 Tablet is primarily utilised in the management of type 2 diabetes mellitus, a metabolic disorder characterised by high blood sugar levels due to insulin resistance or deficiency. This medicine is classified as an oral hypoglycaemic agent.
Glynux M 2 Tablet is indicated for:
• Managing type 2 diabetes mellitus
• Managing polycystic ovary syndrome (PCOS)
For optimal results, adhere to the following guidelines when taking Glynux M 2 Tablet:
• Swallow the tablet whole with a glass of water.
• Do not crush, chew, or break the tablet.
• Take at the same time each day to maintain consistent blood levels.
Glynux M 2 Tablet is taken orally.
Potential side effects of Glynux M 2 Tablet include:
• Diarrhoea
• Nausea
• Vomiting
• Dizziness
Glynux M 2 Tablet consists of two active components:
• Metformin (500 mg): A biguanide that reduces hepatic glucose production and decreases intestinal absorption of glucose, while enhancing insulin sensitivity.
• Glimepiride (2 mg): A sulfonylurea that stimulates pancreatic beta cells to increase insulin secretion, thereby lowering blood glucose levels.
Exercise caution and consult your doctor before taking this medicine if you are pregnant.
Discuss with your doctor prior to using this medicine if you are breastfeeding.
Avoid consuming alcohol as it may interfere with the glucose-lowering effects of the medicine.
Caution is advised in patients with liver conditions due to potential impacts on liver function.
Those with kidney impairment should use this medicine under medical supervision.
As dizziness and drowsiness may occur, exercise caution when driving or operating machinery.
Refrain from using if allergic to glimepiride, metformin, or any other tablet ingredients.
Not recommended for individuals under 18 years of age without medical advice.
Administer under medical supervision, particularly in those over 70 years, due to increased susceptibility to side effects.
Drug-Drug Interactions
Glynux M 2 Tablet interacts with:
• Diuretics: May lead to hypoglycaemia by enhancing glucose-lowering effects.
• Steroids: May elevate blood sugar levels, counteracting the medicine's efficacy.
Drug-Food Interactions
• High-fat meals: Can delay the absorption of glimepiride, affecting its glucose-lowering action.
Drug-Disease Interactions
• Lactic Acidosis: A rare but serious complication, especially in patients with renal, hepatic, or cardiac dysfunction.
• G6PD Deficiency: May cause hemolytic anemia in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Daily Dosage
• The dosage of Glynux M 2 Tablet is taken as per the doctor's prescription, tailored to individual health needs and response to therapy.
Missed Dose
• If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose, in which case, skip the missed dose. Do not double-dose without consulting your doctor.
Overdose
• An overdose may result in symptoms such as nausea, weakness, or diarrhoea. Seek immediate medical attention if overdose symptoms persist or worsen.
• Store in a cool, dry place.
• Keep in the original packaging to protect from light and moisture.
• Keep out of reach of children.
• Maintain a diet low in refined sugars and high in fibre to help manage blood glucose levels.
• Engage in regular physical exercise to enhance insulin sensitivity and the effectiveness of Glynux M 2 Tablet.
.avif)
%20(1).png)
.webp)